Editorial for Treatment-Resistant Depression (TRD)
- PMID: 30753655
- PMCID: PMC6368366
- DOI: 10.1093/ijnp/pyz006
Editorial for Treatment-Resistant Depression (TRD)
Similar articles
-
The role of GRIK4 gene in treatment-resistant depression.Genet Res (Camb). 2015 Jul 3;97:e14. doi: 10.1017/S0016672315000142. Genet Res (Camb). 2015. PMID: 26139080 Free PMC article.
-
Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.Transl Psychiatry. 2016 Mar 8;6(3):e754. doi: 10.1038/tp.2016.18. Transl Psychiatry. 2016. PMID: 26954981 Free PMC article.
-
Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion.J Affect Disord. 2018 Dec 1;241:1-7. doi: 10.1016/j.jad.2018.07.033. Epub 2018 Jul 27. J Affect Disord. 2018. PMID: 30081380
-
Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:117-26. doi: 10.1016/j.pnpbp.2016.03.009. Epub 2016 Apr 1. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 27046518 Review.
-
Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.Trends Pharmacol Sci. 2016 Nov;37(11):933-944. doi: 10.1016/j.tips.2016.09.001. Epub 2016 Sep 28. Trends Pharmacol Sci. 2016. PMID: 27692695 Free PMC article. Review.
Cited by
-
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine.Ann Gen Psychiatry. 2024 May 16;23(1):20. doi: 10.1186/s12991-024-00505-1. Ann Gen Psychiatry. 2024. PMID: 38755657 Free PMC article. Review.
-
The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine.Int J Mol Sci. 2022 Nov 23;23(23):14605. doi: 10.3390/ijms232314605. Int J Mol Sci. 2022. PMID: 36498934 Free PMC article. Review.
-
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.Braz J Psychiatry. 2020;42(3):317-321. doi: 10.1590/1516-4446-2019-0690. Epub 2020 Mar 9. Braz J Psychiatry. 2020. PMID: 32159712 Free PMC article.
References
-
- Bartova L, Dold M, Kautzky A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Schosser A, Kasper S (2019) Results of the European Group for the study of resistant depression (GSRD)—basis for further research and clinical practice. World J Biol Psychiatry (submitted) - PubMed
-
- Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391:1357–1366. - PMC - PubMed
-
- Clinical Pharmacogenetics Implementation Consortium (2014) CPIC Guidelines. Available at: https://cpicpgx.org/guidelines/ Accessed November 27, 2017.
-
- Dold M, Kasper S (2017) Evidence-based pharmacotherapy of treatment-resistant unipolar depression. Int J Psychiatry Clin Pract 21:13–23. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources